首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes.
【24h】

Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes.

机译:封闭的复制叉的核酸内切酶裂解:抗肿瘤药物-拓扑异构酶复合物对DNA的间接损害。

获取原文
获取原文并翻译 | 示例
       

摘要

The cytotoxicity of several important antitumor drugs depends on formation of the covalent topoisomerase-DNA cleavage complex. However, cellular processes such as DNA replication are necessary to convert the cleavage complex into a cytotoxic lesion, but the molecular mechanism of this conversion and the precise nature of the cytotoxic lesion are unknown. Using a bacteriophage T4 model system, we have previously shown that antitumor drug-induced cleavage complexes block replication forks in vivo. In this report, we show that these blocked forks can be cleaved by T4 endonuclease VII to create overt DNA breaks. The accumulation of blocked forks increased in endonuclease VII-deficient infections, suggesting that endonuclease cleavage contributes to fork processing in vivo. Furthermore, purified endonuclease VII cleaved the blocked forks in vitro close to the branch points. These results suggest that an indirect pathway of branched-DNA cleavage contributes to the cytotoxicity of antitumor drugs that target DNA topoisomerases.
机译:几种重要的抗肿瘤药物的细胞毒性取决于共价拓扑异构酶-DNA裂解复合物的形成。然而,诸如DNA复制之类的细胞过程对于将切割复合物转化为细胞毒性损伤是必需的,但是这种转化的分子机制和细胞毒性损伤的确切性质是未知的。使用噬菌体T4模型系统,我们以前已经证明抗肿瘤药物诱导的裂解复合物可阻断体内的复制叉。在此报告中,我们显示了这些受阻的叉子可以被T4核酸内切酶VII切割,从而产生明显的DNA断裂。内切核酸酶VII缺乏感染中受阻叉的积累增加,这表明内切核酸酶的裂解有助于体内的叉加工。此外,纯化的核酸内切酶VII在体外在靠近分支点处切割了封闭的叉子。这些结果表明,分支DNA切割的间接途径有助于靶向DNA拓扑异构酶的抗肿瘤药物的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号